Harvard Bioscience, Inc. (HBIO) Stock Analysis & Investment Frameworks
Harvard Bioscience, Inc. (HBIO) stock analysis on Invetso. Review Harvard Bioscience, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Harvard Bioscience, Inc. Company Overview
- Exchange: NASDAQ
- Sector: Healthcare
- Industry: Medical - Instruments & Supplies
- Country: US
Harvard Bioscience, Inc. Key Financial Metrics
- Market Cap: $37.92M
- Revenue: $86.55M
- ROE: -92.01%
- ROIC: 1.91%
- Dividend Yield: N/A
About Harvard Bioscience, Inc.
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through websites and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic laboratories. It primarily sells its products under the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS, Warner, DSI, Panlab, Hugo Sachs, and Buxco brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.
Harvard Bioscience, Inc. Investment Frameworks
Invetso analyzes Harvard Bioscience, Inc. (HBIO) across the following frameworks:
- Harvard Bioscience, Inc. 10Y Growth Potential
- Harvard Bioscience, Inc. Scenario Analysis
- Harvard Bioscience, Inc. Risks & Opportunities
- Harvard Bioscience, Inc. Economic Moat
- Harvard Bioscience, Inc. Business Model
- Harvard Bioscience, Inc. Management
- Harvard Bioscience, Inc. SWOT Analysis
- Harvard Bioscience, Inc. Porter's 5 Forces
- Harvard Bioscience, Inc. PESTLE Analysis
- Harvard Bioscience, Inc. ESG Analysis